Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
11/2009
11/05/2009US20090275611 Compounds Which Modulate The CB2 Receptor
11/05/2009CA2722122A1 Benzocycloheptane and benzoxepine derivatives
11/04/2009EP2112990A2 Fluorocombretastatin and derivatives thereof
11/04/2009EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
11/03/2009US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009US7612114 Selective estrogen receptor modulator
11/03/2009US7611725 Additives and products including oligoesters
10/2009
10/29/2009WO2009129938A1 Substituted phenoxybenzamides
10/29/2009US20090270478 Ion channel modulating activity ii
10/29/2009US20090270248 Basic ionic liquids
10/29/2009US20090269294 Fragrance Precursor
10/28/2009EP2111223A1 Amine derivative compounds for treating ophthalmic diseases and disorders
10/28/2009CN101565377A Nonyl phenol poly-oxypropylene ether amine
10/28/2009CN101564691A Method for preparing 4,4-diaminodiphenylether and a preparation method of hydrogenation catalyst used therein
10/27/2009CA2465534C Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
10/22/2009WO2009129395A1 Cationic lipids and uses thereof
10/22/2009WO2009129387A2 Cationic lipids and uses thereof
10/22/2009WO2009129385A1 Cationic lipids and uses thereof
10/22/2009US20090263407 Cationic Lipids and Uses Thereof
10/21/2009CN101560166A Method for preparing 1,3-di(2-trifluoromethyl-4-aminophenoxy) benzene
10/21/2009CN101560165A Preparation method of 2,2-bi[4-(2-trifluoromethyl-4-aminophenoxyl)phenyl]hexafluoropropane
10/21/2009CN101560164A Preparation method of 2,5-bi(2-trifluoromethyl-4-aminophenoxyl)toluene
10/21/2009CN101560163A Preparation method of 4,4'-bi(2-trifluoromethyl-4-aminophenoxyl)biphenyl
10/21/2009CN101560162A Preparation method of 4,4'-bi(4-amino-2-trifluoromethylphenoxyl)-3,3'5,5'-tetramethylbiphenyl
10/15/2009WO2009125565A1 Ruthenium compound and method for producing optically active aminoalcohol compound
10/15/2009US20090258948 Pharmaceutical salts
10/14/2009EP1877367B1 Acetylene derivatives
10/14/2009EP1718582B1 Method for selective reduction of aromatic compounds
10/13/2009US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
10/13/2009CA2230047C Imide oligomers and co-oligomers containing pendent phenylethynyl groups and polymers therefrom
10/08/2009WO2009121869A1 Diamine salts of carboxylic acids
10/08/2009WO2008110314A8 Fluoralkylphenylamidines and their use as fungicides
10/07/2009CN101550087A Method for preparing 3-butyl-4-benzyloxy-aniline
10/07/2009CN100546977C New compounds for the inhibition of rotamases and use thereof
10/06/2009US7598421 Lipids such as 2,3-Di-[(Z)-octadec-9-enyloxy]-propyl}-N-(2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy}-ethyl)-N,N-dimethylammonium bromide; integrin-binding peptides
10/06/2009CA2482530C 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
10/01/2009WO2009119858A1 Benzene compound, and use thereof for medical purposes
10/01/2009WO2009118474A1 Method for preparing combretastatin
10/01/2009US20090247642 Synthesis and preparations of metoprolol and its salts
10/01/2009US20090242837 Charge transport compositions and electronic devices made with such compositions
10/01/2009CA2716541A1 Method for preparing combretastatin
09/2009
09/30/2009CN101546887A Method for realizing laser emission conversion on organic crystal frequency through multi-photon pumping
09/29/2009CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions
09/24/2009WO2008047382A3 A process for the preparation of 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol
09/24/2009US20090240082 reacting venlafaxine with aqueous HCl in a solvent containing isopropyl acetate and/or cyclohexane to form venlafaxine hydrochloride form I, crystallization; venlafaxine hydrochloride of form I is added to the venlafaxine; very hight polymorphic purity; azeotropic distillation; by-product reduction
09/23/2009EP2103303A2 Controlled release formulation
09/23/2009CN101538212A Method for preparing 4-hydroxy-3-methoxybenzylamine hydrochloride
09/23/2009CN101538183A New method for preparing 1-substituted-2,2-dimethoxyethylamine hydrochloride
09/17/2009WO2009112703A1 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same
09/17/2009WO2009112461A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
09/17/2009WO2009093916A3 Derivatives of aminoalkanols, method of obtaining aminoalkanols and their use
09/17/2009WO2008119015A3 Synthesis of thiohydantoins
09/17/2009CA2718241A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
09/17/2009CA2712489A1 2-amino-2-phenyl-alkanol derivatives, their preparation and pharmaceutical compositions containing them
09/16/2009EP2100876A2 New compounds for the inhibition of rotamases and use thereof
09/16/2009EP2099740A1 A process for the preparation of optically pure r (-) salbutamol and its pharmaceutically acceptable salts
09/16/2009CN101531602A Method for analyzing and separating formoterol tartrate intermediate by using HPLC method
09/16/2009CN101531599A Green electroluminescent compounds and organic electroluminescent device using the same
09/15/2009US7589127 Aminoalkylphenols, methods of using and making the same
09/15/2009US7589081 High degree of activity induced by the ligands in the activation of readily available but inert chloroaromatic compounds; large scale use; N-phenyl-2-(di-1-adamantyl-phosphino)pyrrole
09/15/2009US7588871 Electrophotographic photoreceptor and image forming apparatus provided with the same
09/11/2009WO2009090669A3 A process for the preparation of 5-chloro-2(2,4-dichlorophenoxy) aniline
09/11/2009WO2009065406A3 Novel cyclic hydrocarbon compounds for the treatment of diseases
09/10/2009US20090227682 Xetine compositions
09/09/2009EP2097383A2 Process for preparation of ivabradine hydrochloride
09/09/2009EP2014643A4 Para-ethoxyaniline derivatives increasing the antiknock rating of hydrocarbon fuels and compositions based thereon
09/09/2009EP1487573B1 Catalysts and method for the production of amines
09/09/2009CN101528669A Deuterated aminoglycidyl compounds
09/09/2009CN101525298A Circulation clean production method of N-propoxyl ethyl-2, 6-diethylaniline
09/08/2009CA2292017C Substituted cycloheptenes, their preparation and use
09/03/2009WO2009106386A1 Process of preparation of optically active alpha aminoacetals
09/03/2009CA2716665A1 Process of preparation of optically active alpha aminoacetals
09/02/2009EP2096104A1 Organic diamines as mGluR7 modulators
09/02/2009CN101519359A Method for recovering polyimide through hydrolysis
09/01/2009US7582765 Aryl aniline β2 adrenergic receptor agonists
08/2009
08/27/2009US20090216015 Base Stable Ionic Liquids
08/27/2009US20090215067 Novel lipids for transfection of nucleic acids
08/26/2009EP2091955A1 Alkoxy compounds for disease treatment
08/26/2009EP2091928A2 3-(2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
08/26/2009EP1720823B1 New process for the synthesis of substituted alpha-aminoidan derivatives
08/26/2009CN101516863A A process for the preparation of substituted 2-acetylamino-alkoxyphenyl
08/26/2009CN101516830A Method for the continuous separation by distillation of mixtures that contain morpholine (mo), monoaminodiglycol (adg), ammonia and water
08/26/2009CN101516829A Method for producing high-purity quaternary ammonium salt
08/26/2009CN100532355C Technique for synthesizing levorotatory betaxolol hydrochloride
08/26/2009CN100532353C Preparation process of (Z)-3'-amino-3,4,4', 5-tetramethoxyl stilbene
08/26/2009CN100531732C Thiomolybdate analogues
08/25/2009US7579507 Polymorphic crystal of 4′-{2-[ (1S, 2R)—2- hydroxy-2- (4-hydroxyphenyl)-1-methylethylamino]ethoxy} - 3 - isopropyl-3′, 5′ -dimethylbiphenyl- 4 - carboxylic acid hydrochloride
08/19/2009EP2090565A2 Ionic liquids
08/19/2009EP2089354A1 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
08/19/2009CN101511775A Butyl and butynyl benzyl amine compounds
08/19/2009CN101511175A Alkoxylated alkylamines/alkyl ether amines with peaked distribution
08/19/2009CN101508653A Synthesis of meta-methoxy diphenylamine
08/19/2009CN101508652A Hyperpiesis resistant compound and method of preparing the same
08/19/2009CN100528833C Alkyl multicondensed ethylene glycol derivative, its preparation method and application
08/19/2009CN100528832C Technique of synthesizing levorotatory betaxolol hydrochloride
08/18/2009US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide
08/18/2009US7576234 Synthesis of 2-alkyl amino acids
08/18/2009CA2333004C Formoterol polymorphs
08/13/2009US20090202572 Compositions and methods for modulating bone mass
08/13/2009US20090200933 Triarylamine compounds, compositions and uses therefor
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 140